<VariationArchive RecordType="classified" VariationID="2627019" VariationName="NM_198489.3(CENATAC):c.805+2_805+19del" VariationType="Deletion" Accession="VCV002627019" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-11-04" DateCreated="2023-10-28" MostRecentSubmission="2023-10-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2794539" VariationID="2627019">
      <GeneList>
        <Gene Symbol="CENATAC" FullName="centrosomal AT-AC splicing factor" GeneID="338657" HGNC_ID="HGNC:30460" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="118998138" stop="119015793" display_start="118998138" display_stop="119015793" Strand="+" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_009646203.1" start="19738" stop="37393" display_start="19738" display_stop="37393" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118868851" stop="118886454" display_start="118868851" display_stop="118886454" Strand="+" />
          </Location>
          <OMIM>620142</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_198489.3(CENATAC):c.805+2_805+19del</Name>
      <CanonicalSPDI>NC_000011.10:119015081:AAGTAAGTAAACTAATTCAAG:AAG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119015082" stop="119015099" display_start="119015082" display_stop="119015099" variantLength="18" positionVCF="119015081" referenceAlleleVCF="AAAGTAAGTAAACTAATTC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="118885792" stop="118885809" display_start="118885792" display_stop="118885809" variantLength="18" positionVCF="118885791" referenceAlleleVCF="AAAGTAAGTAAACTAATTC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.119015085_119015102del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.119015085_119015102del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.118885795_118885812del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.118885795_118885812del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_050577.1" sequenceAccession="NG_050577" sequenceVersion="1" change="g.25733_25750del">
            <Expression>NG_050577.1:g.25733_25750del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_198489.3" sequenceAccession="NM_198489" sequenceVersion="3" change="c.805+2_805+19del" MANESelect="true">
            <Expression>NM_198489.3:c.805+2_805+19del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001575" Type="splice donor variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="620142.0001" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_198489.3(CENATAC):c.805+2_805+19del AND Mosaic variegated aneuploidy syndrome 4" Accession="RCV003387706" Version="1">
        <ClassifiedConditionList TraitSetID="82503">
          <ClassifiedCondition DB="MedGen" ID="C5774267">Mosaic variegated aneuploidy syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2022-12-07" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-12-07" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-28" MostRecentSubmission="2023-10-28">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">34009673</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="82503" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="66346" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Mosaic variegated aneuploidy syndrome 4</ElementValue>
                <XRef ID="MONDO:0859329" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MVA4</ElementValue>
                <XRef Type="MIM" ID="620153" DB="OMIM" />
              </Symbol>
              <XRef ID="C5774267" DB="MedGen" />
              <XRef ID="MONDO:0859329" DB="MONDO" />
              <XRef Type="MIM" ID="620153" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7676247" SubmissionDate="2022-12-07" DateLastUpdated="2023-10-28" DateCreated="2023-10-28">
        <ClinVarSubmissionID localKey="620142.0001_MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 4 (1 family)" title="CENATAC, 18-BP DEL, NT805+2_MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 4 (1 family)" />
        <ClinVarAccession Accession="SCV004099274" DateUpdated="2023-10-28" DateCreated="2023-10-28" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-07">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamilies="1" />
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs (case IDs 5728_1 and 5728_2) with mosaic variegated aneuploidy syndrome (MVA4; 620142), de Wolf et al. (2021) identified compound heterozygosity for mutations in the CENATAC gene: an intronic deletion (c.805+2_805+19del18), and a c.803A-T transversion, resulting in a glu268-to-val (E268V; 620142.0002) substitution. Both mutations create novel splice sites that cause frameshifts resulting in loss of the 64 amino acids making up the 2 most C-terminal of 4 well-conserved C-terminal sequence motifs. Their unaffected parents were each heterozygous for one of the mutations, neither of which was found in an unaffected sib or in the ICR1000 or ExAC databases. Functional analysis in CENATAC-depleted HeLa cells demonstrated chromosome congression defects and subsequent mitotic arrest, which could be fully rescued by wildtype but not mutant CENATAC. Expression of the MVA-associated mutants exacerbated the phenotype, suggesting that the mutant proteins dominantly repress the function of any residual wildtype protein. Patient cells showed impairment of splicing of minor introns, with retention predominantly of A-type introns, and the minor intron splicing defect in CENATAC-depleted cells could be rescued by wildtype but not mutant CENATAC. In addition, the extent of the splicing defect strongly correlated with the extent of the mitotic phenotype.</Attribute>
              <Citation>
                <ID Source="PubMed">34009673</ID>
              </Citation>
              <XRef DB="OMIM" ID="620142" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CENATAC" />
          </GeneList>
          <Name>CENATAC, 18-BP DEL, NT805+2</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">18-BP DEL, NT805+2</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="620142.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 4 (1 family)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
  </ClassifiedRecord>
</VariationArchive>

